Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFDINIR vs CEFEPIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFDINIR vs CEFEPIME: Safety Overview

Metric CEFDINIR CEFEPIME
Total FAERS Reports 1,627 5,540
Deaths Reported 35 997
Death Rate 2.2% 18.0%
Hospitalizations 262 3,055
Average Patient Age 37.8 yrs 56.5 yrs
% Female Patients 65.6% 47.6%
FDA Approval Date Apr 6, 2007 Aug 21, 2018
Manufacturer Sandoz Inc Apotex Corp.
Route ORAL INTRAMUSCULAR
Marketing Status Discontinued Discontinued